Diffusion-Weighted MR Imaging and MGMT Methylation Status in Glioblastoma: A Reappraisal of the Role of Preoperative Quantitative ADC Measurements

References

1. 1.↵
   1. Kim YS,
   2. Kim SH,
   3. Cho J,
   4. et al

   . MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study. Int J Radiat Oncol Biol Phys 2012;84:661–67

   CrossRefPubMed
2. 2.↵
   1. Pope WB,
   2. Lai A,
   3. Mehta R,
   4. et al

   . Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol 2011;32:882–89

   Abstract/FREE Full Text
3. 3.↵
   1. Law M,
   2. Young R,
   3. Babb J,
   4. et al

   . Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007;28:761–66

   Abstract/FREE Full Text
4. 4.↵
   1. Wetzel SG,
   2. Cha S,
   3. Johnson G,
   4. et al

   . Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803

   Abstract/FREE Full Text